Showing 1281-1290 of 10594 results for "".
Electromagnetic Therapy Improves Survival in Patients with Aggressive Type of Brain Cancer
https://reachmd.com/programs/the-jama-report/electromagnetic-therapy-improves-survival-patients-aggressive-type-brain-cancer/7863/[Read the Article] Glioblastoma is the most devastating form of brain cancer in adults; most patients die within one to two years of diagnosis. A new study examined whether using tumor-treating fields, a type of electromagnetic therapy, combined with maintenance chemotherapy in patients with glioblaTestosterone Therapy Neither Advances Nor Slows Down Hardening of the Arteries in Older Men with Low Testosterone Levels
https://reachmd.com/programs/the-jama-report/testosterone-therapy-neither-advances-nor-slows-down-hardening-arteries-older-men-low-testosterone/7640/[Read the Article] The popularity of testosterone supplementation among older men has increased substantially over the past decade. However, the risks and benefits of long-term administration are still unclear. A new study examined whether using testosterone supplements affected the development of aDeciphering the Link: Proteinuria and eGFR Dynamics in IgAN and FSGS
https://reachmd.com/programs/clinicians-roundtable/deciphering-the-link-proteinuria-and-egfr-dynamics-in-igan-and-fsgs/37215/High levels of proteinuria are associated with a high risk of kidney failure in the future, both for IgA nephropathy (IgAN) and focal segmental glomerulosclerosis (FSGS). In fact, proteinuria levels can help predict disease progression, outcomes, and even optimal therapeutic approaches. Joining Dr.The Past, Present, and Future of Metastatic Breast Cancer Care
https://reachmd.com/programs/frontlines-metastatic-breast-cancer/the-past-present-and-future-of-metastatic-breast-cancer-care/39718/Metastatic breast cancer care has evolved dramatically over the past century, driven by advances in our understanding of tumor biology and systemic therapy. From early insights into the role of estrogen to the development of HER2-targeted treatments and precision medicine approaches, these milestoneConcurrent Atezolizumab Fails to Improve Survival in Limited-Stage SCLC
https://reachmd.com/programs/project-oncology/concurrent-atezolizumab-fails-to-improve-survival-in-limited-stage-sclc/56338/The SMART Protocol in Mesothelioma: Challenges and Opportunities for Global Adoption
https://reachmd.com/programs/project-oncology/program-name/36560/While early findings using the SMART protocol for mesothelioma have been encouraging, replication has proven challenging due to steep surgical learning curves, complexities in planning, and skepticism. Dr. John Cho explores why adoption has been limited and what's next for this approach, which he diDisaster-Proofing Colorectal Cancer Screening: What We Learned from COVID-19
https://reachmd.com/programs/clinicians-roundtable/disaster-proofing-colorectal-cancer-screening-what-we-learned-from-covid-19/36480/Colorectal cancer screening saw significant disruptions during the COVID-19 pandemic, a challenge that has also been reflected during natural disasters such as hurricanes and wildfires. Dr. Gloria Coronado joins Dr. Charles Turck to discuss how these kinds of crises impact screening rates and how aOvercoming Controversies of Irritable Bowel Syndrome
https://reachmd.com/programs/gi-insights/overcoming-controversies-of-irritable-bowel-syndrome/18100/Dive in to learn about solutions to controversies surrounding IBS.Gazing into the Cardiology Crystal Ball: The Future of Preventive Care
https://reachmd.com/programs/heart-matters/gazing-into-the-cardiology-crystal-ball-the-future-of-preventive-care/12032/How will the changing healthcare system impact preventative cardiology and the overall health of the population?Building a New Tower at Hadassah Medical Center
https://reachmd.com/programs/focus-on-future-medicine-and-genetics/building-a-new-tower-at-hadassah-medical-center/5992/What lessons can we learn from a state-of-the-art medical center in Jerusalem? Dr. Shlomo Mor-Yosef, director general of Hadassah Medical Center, talks with host Dr. Matthew Birnholz about the day-to-day workings of this level 1 trauma center on contentious ground.